These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 23013350)

  • 21. Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer's disease.
    Turunc Bayrakdar E; Uyanikgil Y; Kanit L; Koylu E; Yalcin A
    Free Radic Res; 2014 Feb; 48(2):146-58. PubMed ID: 24151909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood-brain barrier after traumatic brain injury in mice.
    Tao X; Chen X; Hao S; Hou Z; Lu T; Sun M; Liu B
    Neuroscience; 2015 Apr; 291():26-36. PubMed ID: 25668593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Candesartan attenuates ischemic brain edema and protects the blood-brain barrier integrity from ischemia/reperfusion injury in rats.
    Panahpour H; Nekooeian AA; Dehghani GA
    Iran Biomed J; 2014; 18(4):232-8. PubMed ID: 25326022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurological and histological consequences induced by in vivo cerebral oxidative stress: evidence for beneficial effects of SRT1720, a sirtuin 1 activator, and sirtuin 1-mediated neuroprotective effects of poly(ADP-ribose) polymerase inhibition.
    Gueguen C; Palmier B; Plotkine M; Marchand-Leroux C; Besson VC
    PLoS One; 2014; 9(2):e87367. PubMed ID: 24586272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia.
    Egi Y; Matsuura S; Maruyama T; Fujio M; Yuki S; Akira T
    Brain Res; 2011 May; 1389():169-76. PubMed ID: 21420942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
    Kabra DG; Thiyagarajan M; Kaul CL; Sharma SS
    Brain Res Bull; 2004 Feb; 62(5):425-33. PubMed ID: 15168908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydrogen-rich saline reduces cell death through inhibition of DNA oxidative stress and overactivation of poly (ADP-ribose) polymerase-1 in retinal ischemia-reperfusion injury.
    Liu H; Hua N; Xie K; Zhao T; Yu Y
    Mol Med Rep; 2015 Aug; 12(2):2495-502. PubMed ID: 25954991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contributions of poly(ADP-ribose) polymerase-1 and -2 to nuclear translocation of apoptosis-inducing factor and injury from focal cerebral ischemia.
    Li X; Klaus JA; Zhang J; Xu Z; Kibler KK; Andrabi SA; Rao K; Yang ZJ; Dawson TM; Dawson VL; Koehler RC
    J Neurochem; 2010 May; 113(4):1012-22. PubMed ID: 20236222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
    Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
    Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals.
    Koh SH; Park Y; Song CW; Kim JG; Kim K; Kim J; Kim MH; Lee SR; Kim DW; Yu HJ; Chang DI; Hwang SJ; Kim SH
    Eur J Neurosci; 2004 Sep; 20(6):1461-72. PubMed ID: 15355313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel and orally active poly(ADP-ribose) polymerase inhibitor, KR-33889 [2-[methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1H-benzimidazole-4-carboxylic acid amide], attenuates injury in in vitro model of cell death and in vivo model of cardiac ischemia.
    Oh KS; Lee S; Yi KY; Seo HW; Koo HN; Lee BH
    J Pharmacol Exp Ther; 2009 Jan; 328(1):10-8. PubMed ID: 18836068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effects of poly (ADP-ribose) polymerase inhibitors in transient focal cerebral ischemia of rats.
    Sun AY; Cheng JS
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):104-8. PubMed ID: 10374629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of irbesartan, an angiotensin II receptor antagonist, alone and in combination with aspirin on middle cerebral artery occlusion model of focal cerebral ischemia in rats.
    Pratap R; Pillai KK; Khanam R; Islam F; Ahmad SJ; Akhtar M
    Hum Exp Toxicol; 2011 May; 30(5):354-62. PubMed ID: 20488839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. By improving regional cortical blood flow, attenuating mitochondrial dysfunction and sequential apoptosis galangin acts as a potential neuroprotective agent after acute ischemic stroke.
    Li S; Wu C; Zhu L; Gao J; Fang J; Li D; Fu M; Liang R; Wang L; Cheng M; Yang H
    Molecules; 2012 Nov; 17(11):13403-23. PubMed ID: 23143152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of neuronal nitric oxide synthase-mediated activation of poly(ADP-ribose) polymerase in traumatic brain injury: neuroprotection by 3-aminobenzamide.
    Hortobágyi T; Görlach C; Benyó Z; Lacza Z; Hortobágyi S; Wahl M; Harkany T
    Neuroscience; 2003; 121(4):983-90. PubMed ID: 14580948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury.
    Park EM; Cho S; Frys K; Racchumi G; Zhou P; Anrather J; Iadecola C
    Stroke; 2004 Dec; 35(12):2896-901. PubMed ID: 15514191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain.
    Schmerbach K; Schefe JH; Krikov M; Müller S; Villringer A; Kintscher U; Unger T; Thoene-Reineke C
    Brain Res; 2008 May; 1208():225-33. PubMed ID: 18378216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors.
    Giovannelli L; Cozzi A; Guarnieri I; Dolara P; Moroni F
    J Cereb Blood Flow Metab; 2002 Jun; 22(6):697-704. PubMed ID: 12045668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation.
    Kaundal RK; Shah KK; Sharma SS
    Life Sci; 2006 Nov; 79(24):2293-302. PubMed ID: 16935310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly (ADP-ribose) polymerase-1: an emerging target in right ventricle dysfunction associated with pulmonary hypertension.
    Kaur G; Singh N; Lingeshwar P; Siddiqui HH; Hanif K
    Pulm Pharmacol Ther; 2015 Feb; 30():66-79. PubMed ID: 25481773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.